| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 8,802,000 | 8,938,000 | 8,835,000 | 8,765,000 | | Cost of Revenue | (7,110,000) | 3,545,000 | 3,565,000 | 4,179,000 | | | Gross Profit | 15,912,000 | 5,393,000 | 5,270,000 | 4,586,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 12,586,000 | 1,858,000 | 1,826,000 | 1,216,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,615,000 | 1,660,000 | 1,633,000 | 1,613,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,711,000 | 1,875,000 | 1,811,000 | 1,757,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 150,000 | 69,000 | 12,000 | (584,000) | | Earnings Before Interest And Taxes | 1,844,000 | 1,931,000 | 1,809,000 | 1,180,000 | | Interest Expense | 707,000 | 551,000 | 570,000 | 599,000 | | Income Before Tax | 1,137,000 | 1,380,000 | 1,239,000 | 581,000 | | Income Tax Expense | 203,000 | 424,000 | 461,000 | 169,000 | | Minority Interest | 10,000 | 5,000 |
-
|
-
| | | | Net Income From Continuing Ops | 900,000 | 961,000 | 778,000 | 412,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 944,000 | 961,000 | 778,000 | 412,000 | | Preferred Stock And Other Adjustments |
-
| 6,000 | (6,000) |
-
| | | Net Income Applicable To Common Shares | $944,000 | $967,000 | $772,000 | $412,000 |
|
0.19% Nasdaq 
Income Statement
